Related Experiment Video
Updated: Jul 2, 2026
07:27
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
11.7K
Serum miR-30b is increased in Labrador Retrievers with elevated hepatic copper levels
Yara S Roelen1, Bart Spee2, Monique E van Wolferen2
1Anicura 'De Tweede Lijn', Zwolle, the Netherlands.
Veterinary Journal (London, England : 1997)
|March 7, 2025
Summary
This study identified cfa-miR-30b as a potential biomarker for copper-associated hepatitis in Labrador Retrievers. This microRNA is elevated in dogs with high hepatic copper levels, offering a less invasive diagnostic approach.
Area of Science:
- Veterinary Medicine
- Genetics
- Biochemistry
Background:
- Copper-associated hepatitis is a hereditary liver disease in Labrador Retrievers requiring invasive diagnostics.
- Current diagnostic methods for hepatic copper levels involve liver biopsies.
- A non-invasive serum biomarker is needed for diagnosis and monitoring.
Purpose of the Study:
- To identify microRNAs (miRNAs) associated with elevated hepatic copper levels in Labrador Retrievers.
- To explore circulating miRNAs as potential biomarkers for copper-associated hepatitis.
- To investigate the diagnostic potential of miRNAs in canine hepatobiliary disease.
Main Methods:
- Retrospective selection of Labrador Retrievers with normal and elevated hepatic copper levels.
- Serum miRNA screening array analysis of 277 miRNAs.
- Quantitative real-time PCR (qPCR) validation of upregulated miRNAs in a replication cohort.
Main Results:
- Six serum miRNAs were significantly upregulated in dogs with elevated hepatic copper.
- Following Bonferroni correction, cfa-miR-30b was significantly upregulated (fold-change 2.17, p-value 0.002) in the replication cohort.
- This pilot study identified cfa-miR-30b as a potential indicator of increased hepatic copper.
Conclusions:
- Circulating cfa-miR-30b is increased in Labrador Retrievers with elevated hepatic copper levels.
- Cfa-miR-30b shows potential as a non-invasive biomarker for copper-associated hepatitis.
- Further validation in larger, diverse cohorts is warranted to confirm these findings.
Related Concept Videos
01:30Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.